SCHEMBL1805554

SCHEMBL1805554

CC(O)C(=O)Oc1ccc(O)c(O)c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 2/20 0.47
KDM4E B2RXH2 2/20 0.47
RECQL P46063 2/20 0.47
DBH P09172 1/20 0.47
CA12 O43570 4/20 0.43
CA1 P00915 4/20 0.43
CA2 P00918 4/20 0.43
CA7 P43166 4/20 0.43
CA9 Q16790 4/20 0.43
CA14 Q9ULX7 4/20 0.43
ADRB2 P07550 3/20 0.43
ADRB1 P08588 1/20 0.43
ELANE P08246 1/20 0.42
XBP1 P17861 1/20 0.40
ATM Q13315 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
XDH P47989 1/20 0.39
NPC1 O15118 1/20 0.38
RAB9A P51151 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28477219 1.00 GAA (0.47) GAAKDM4ERECQLDBHCA12
SCHEMBL28348813 1.00 GAA (0.47) GAAKDM4ERECQLDBHCA12
SCHEMBL242554 0.84 CA2 (0.42) GAAKDM4ERECQLDBHCA12
SCHEMBL28497994 0.83 TSHR (0.50) GAAKDM4ENPSR1RAB9ATSHR
SCHEMBL28184139 0.82 ELANE (0.50) GAAKDM4ECA12CA1CA2
SCHEMBL28183245 0.82 ELANE (0.50) GAAKDM4ECA12CA1CA2
SCHEMBL624333 0.82 ELANE (0.50) GAAKDM4ECA12CA1CA2
SCHEMBL27493344 0.82 ATM (0.61) GAAXBP1ATMNPSR1L3MBTL1
SCHEMBL10787310 0.80 CYP3A4 (0.62) KDM4EADRB2ADRB1ATML3MBTL1
SCHEMBL1052924 0.78 ALDH1A1 (0.52) GAAKDM4ERECQLDBHCA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 82 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170087280-A1 SPATIOTEMPORALLY MULTICONTROLLABLE INTELIGENT DRUG-ELUTING STENT KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) 2017-03-30 US claimed
CN-102030648-B Asymmetric synthesis method of 3-(3,4-dihydroxy phenyl)-2-hydracrylate UNIV NORTHWESTERN 2013-04-03 CN claimed
US-20050037094-A1 Composition for heart disease, its active ingredients, method to prepare same and uses thereof TIANJIN TASLY PHARMACEUTICAL CO., LTD., CHINA (CN) 2005-02-17 US claimed
EP-4658091-A1 COMPOUNDS Givaudan SA (CH) 2025-12-10 EP disclosed
WO-2024160955-A1 COMPOUNDS GIVAUDAN SA (CH) 2024-08-08 WO disclosed
CN-117959200-B Modified mica, anti-wrinkle concealer containing modified mica of salvia miltiorrhiza extract and preparation method of anti-wrinkle concealer 广东碧茜生物科技有限公司 2024-07-16 CN disclosed
CN-118272328-A Caffeoyl-CoA ligase mutant protein, encoding gene, recombinant vector, recombinant bacterium and application thereof 扬州大学 2024-07-02 CN disclosed
CN-118206513-A Salvianolic acid B micromolecular active probe and preparation method and application thereof 中国中医科学院中药研究所 2024-06-18 CN disclosed
CN-117959200-A Modified mica, anti-wrinkle concealer containing modified mica of salvia miltiorrhiza extract and preparation method of anti-wrinkle concealer 广东碧茜生物科技有限公司 2024-05-03 CN disclosed
CN-117598399-A Extract containing rosmarinic acid and application thereof 湖南德诺健康产业集团有限公司 2024-02-27 CN disclosed
CN-117467678-A Method for producing tanshinol 上海中医药大学 2024-01-30 CN disclosed
WO-2002058625-A2 HERBAL COMPOSITION FOR ANGINA PECTORIS, METHOD TO PREPARE SAME AND USES THEREOF TIANJIN TASLY PHARMACEUTICAL CO., LTD., CHINA (CN) 2002-08-01 WO disclosed
WO-2001000199-A9 COMPOUNDS OBTAINED FROM SALVIA SPECIES HAVING ANTIVIRAL ACTIVITY UNIV GEORGETOWN (US) 2002-06-13 WO disclosed
EP-1206255-A1 COMPOUNDS OBTAINED FROM i SALVIA SPECIES /i HAVING ANTIVIRAL ACTIVITY GEORGETOWN UNIVERSITY (US) 2002-05-22 EP disclosed
EP-1089747-A1 COMPOUNDS OBTAINED FROM SALVIA SPECIES HAVING ANTIVIRAL ACTIVITY GEORGETOWN UNIVERSITY (US) 2001-04-11 EP disclosed
WO-2001000199-A1 COMPOUNDS OBTAINED FROM SALVIA SPECIES HAVING ANTIVIRAL ACTIVITY GEORGETOWN UNIVERSITY (US) 2001-01-04 WO disclosed
CN-1056068-C Red sage root use for antivirus of AIDS and hepatitis B INST OF MEDICINE BIOTECHNOLOGY (CN) 2000-09-06 CN disclosed
WO-1999066942-A9 COMPOUNDS OBTAINED FROM SALVIA SPECIES HAVING ANTIVIRAL ACTIVITY UNIV GEORGETOWN (US) 2000-06-22 WO disclosed
US-6043276-A SALVIANOLIC ACID DIMERS, TRIMERS, TETRAMERS AND LARGER POLYMERS GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE (US) 2000-03-28 US disclosed
WO-1999066942-A1 COMPOUNDS OBTAINED FROM SALVIA SPECIES HAVING ANTIVIRAL ACTIVITY GEORGETOWN UNIVERSITY (US) 1999-12-29 WO disclosed